GlassScriptPhysician profile
Daniel Fung
NPI 1497012199
$16,448.72
in general payments reported to CMS, 2019-2025
25 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,089 · 2020: $838 · 2021: $769 · 2022: $2,575 · 2023: $5,353 · 2024: $3,348 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,984 · Travel and Lodging: $2,445 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,983.72 |
| Travel and Lodging | $2,444.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $6,136.61 | 2019-2025 | Ruby Coil, Indigo System, Penumbra System |
| Boston Scientific Corporation | $5,697.35 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Eluvia |
| Biocompatibles, INC. | $1,008.91 | 2019 | |
| Medtronic USA, INC. | $552.41 | 2019 | |
| Terumo Medical Corporation | $483.01 | 2024-2025 | Navicross, Azur Cx Detachable |
| Sirtex Medical INC | $395.48 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Inari Medical, INC. | $366.62 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $340.55 | 2020-2024 | |
| Medtronic Vascular, INC. | $304.36 | 2019 | |
| Histosonics, INC. | $302.13 | 2025 | |
| Okami Medical, INC. | $134.97 | 2024 | Lobo |
| Ethicon US, LLC | $120.88 | 2021-2025 | Neuwave |
| Medical Device Business Services, INC. | $113.94 | 2020 | |
| Abbott Laboratories | $92.08 | 2022-2024 | Xience Skypoint, Dragonfly Opstar, Optis |
| Cordis US Corp. | $88.65 | 2025 | Mynx Control Venous |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $87.15 | 2020-2021 | |
| Medtronic, INC. | $45.27 | 2023 | Ellipsys Vascular Access System |
| Angiodynamics, INC. | $42.17 | 2020 | |
| Itamar Medical INC | $28.72 | 2022 | |
| Lantheus Medical Imaging, INC. | $22.88 | 2022 | |
| Abiomed | $20.06 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $17.27 | 2022 | |
| Cook Medical LLC | $17.19 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.07 | 2025 | Jardiance |
| Merit Medical Systems INC | $14.99 | 2024 | Microsphere Embospheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.